In a highly anticipated announcement, Pfizer said a Phase 2/3 trial showed its Covid-19 vaccine was safe and generated a “robust” antibody response in children ages 5 to 11.
Fuente: Youtube
In a highly anticipated announcement, Pfizer said a Phase 2/3 trial showed its Covid-19 vaccine was safe and generated a “robust” antibody response in children ages 5 to 11.
Fuente: Youtube